Evan Newell, Ph.D.
Evan Newell, Ph.D.
Associate Member
Vaccine and Infectious Disease Division, Fred Hutch
Joint Associate Member
Computational Biology Program in PHS
Dr. Evan Newell is an immunologist who employs new technologies for identifying specific, accurate biological signatures of human health and disease, including cancer. His search for these biomarkers is focused on antigens, a wide variety of small proteins recognized by immune cells called T cells. The shape of these antigens on cell surfaces help T cells determine if something is foreign, abnormal or potentially dangerous. Dr. Newell’s team is cataloging the different ways in which T cell respond to different antigens, particularly those associated with cancer cells.
Education
Ph.D. Physiology, University of Toronto, Canada, 2006
B.Sc. Immunology, McGill University, Canada, 2000
Research Interests
Human T cell immunology
Development and application of novel methods for identifying and characterizing antigen specific T cells in the context of cancer and chronic infection with the goal of identifying specific and accurate biomarkers of human health and disease based on antigen-specific T cells
Current Projects
Exploiting T cell antigen-specificity to gain clinically relevant insights about cancer and infectious disease
Development of novel methods for profiling antigen-specific T cell responses
Visualizing and comparing the high dimensional diversity of immune cells
“A lot of people here, like me, are working on T cells. We want to know exactly what they are recognizing on cancer cells and what they are doing differently in different people.”
—Dr. Evan Newell
For the Media
The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.
Email media@fredhutch.org or call 206.667.2210